dc.contributorMayo Clinic
dc.contributorUniversity of Utah School of Medicine
dc.contributorThe Children's Hospital of Philadelphia
dc.contributorThe University of Chicago Medical Center
dc.contributorDuke University School of Medicine
dc.contributorMedical University of Gdansk
dc.contributorUniversity of Missouri-Kansas City
dc.contributorIrccs Ospedale Pediatrico Bambino Gesù
dc.contributorInstitute of Rheumatology
dc.contributorColumbia University Medical Center
dc.contributorGeorge Washington University School of Medicine and Health Sciences
dc.contributorNational Institute of Arthritis and Musculoskeletal and Skin Diseases
dc.contributorUniversity of Texas McGovern Medical School at Houston
dc.contributorEmory University School of Medicine
dc.contributorUniversidade Federal do Rio de Janeiro (UFRJ)
dc.contributorHospital Sant Joan de Déu
dc.contributorBarcelona
dc.contributorUniversidade Estadual de Campinas (UNICAMP)
dc.contributorRiley Hospital for Children at Indiana University Health
dc.contributorUniversidade Estadual Paulista (UNESP)
dc.contributorMelbourne and Murdoch Children's Research Institute
dc.contributorUniversity of Florida
dc.contributorHospital General Universitario Gregorio Marañón
dc.contributorHarvard Medical School
dc.contributorTokyo Metropolitan Tama Medical Center
dc.contributorUniversity of Iowa
dc.date.accessioned2022-04-29T08:30:47Z
dc.date.accessioned2022-12-20T02:48:01Z
dc.date.available2022-04-29T08:30:47Z
dc.date.available2022-12-20T02:48:01Z
dc.date.created2022-04-29T08:30:47Z
dc.date.issued2021-07-01
dc.identifierRheumatology (United Kingdom), v. 60, n. 7, p. 3144-3155, 2021.
dc.identifier1462-0332
dc.identifier1462-0324
dc.identifierhttp://hdl.handle.net/11449/229166
dc.identifier10.1093/rheumatology/keaa757
dc.identifier2-s2.0-85110554975
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/5409300
dc.description.abstractObjective: Sjögren syndrome in children is a poorly understood autoimmune disease. We aimed to describe the clinical and diagnostic features of children diagnosed with Sjögren syndrome and explore how the 2016 ACR/EULAR classification criteria apply to this population. Methods: An international workgroup retrospectively collected cases of Sjögren syndrome diagnosed under 18 years of age from 23 centres across eight nations. We analysed patterns of symptoms, diagnostic workup, and applied the 2016 ACR/EULAR classification criteria. Results: We identified 300 children with Sjögren syndrome. The majority of patients n = 232 (77%) did not meet 2016 ACR/EULAR classification criteria, but n = 110 (37%) did not have sufficient testing done to even possibly achieve the score necessary to meet criteria. Even among those children with all criteria items tested, only 36% met criteria. The most common non-sicca symptoms were arthralgia [n = 161 (54%)] and parotitis [n = 140 (47%)] with parotitis inversely correlating with age. Conclusion: Sjögren syndrome in children can present at any age. Recurrent or persistent parotitis and arthralgias are common symptoms that should prompt clinicians to consider the possibility of Sjögren syndrome. The majority of children diagnosed with Sjögren syndromes did not meet 2016 ACR/EULAR classification criteria. Comprehensive diagnostic testing from the 2016 ACR/EULAR criteria are not universally performed. This may lead to under-recognition and emphasizes a need for further research including creation of paediatric-specific classification criteria.
dc.languageeng
dc.relationRheumatology (United Kingdom)
dc.sourceScopus
dc.subjectchildhood Sjögren syndrome
dc.subjectpediatric rheumatology
dc.subjectrecurrent parotitis
dc.subjectSjögren Syndrome
dc.titleChildhood Sjögren syndrome: Features of an international cohort and application of the 2016 ACR/EULAR classification criteria
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución